

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 6.09568031 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 6.09568031 |
| 3 | fatty acid elongation (GO:0030497) | 4.48972872 |
| 4 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.59490085 |
| 5 | neuronal action potential propagation (GO:0019227) | 3.43756836 |
| 6 | myelination (GO:0042552) | 3.41761435 |
| 7 | L-amino acid import (GO:0043092) | 3.41661188 |
| 8 | axon ensheathment (GO:0008366) | 3.38931680 |
| 9 | ensheathment of neurons (GO:0007272) | 3.38931680 |
| 10 | negative regulation of neurotransmitter transport (GO:0051589) | 3.15760977 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.09934560 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 3.08572642 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.04580294 |
| 14 | negative regulation of cell killing (GO:0031342) | 3.04580294 |
| 15 | synaptic vesicle maturation (GO:0016188) | 3.00804711 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.97494230 |
| 17 | cellular potassium ion homeostasis (GO:0030007) | 2.97357840 |
| 18 | response to methylmercury (GO:0051597) | 2.96954667 |
| 19 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.93309182 |
| 20 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.88455950 |
| 21 | substantia nigra development (GO:0021762) | 2.86228191 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83474824 |
| 23 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.82296946 |
| 24 | cellular copper ion homeostasis (GO:0006878) | 2.77856398 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.76424185 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75877321 |
| 27 | amino acid import (GO:0043090) | 2.75687253 |
| 28 | negative regulation of protein localization to cell surface (GO:2000009) | 2.73159221 |
| 29 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.72421377 |
| 30 | oligodendrocyte differentiation (GO:0048709) | 2.68564185 |
| 31 | glycosylceramide metabolic process (GO:0006677) | 2.65219435 |
| 32 | amyloid precursor protein metabolic process (GO:0042982) | 2.62941742 |
| 33 | myelin maintenance (GO:0043217) | 2.59943894 |
| 34 | neuron cell-cell adhesion (GO:0007158) | 2.59779090 |
| 35 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.59593888 |
| 36 | actin nucleation (GO:0045010) | 2.58818256 |
| 37 | regulation of synaptic vesicle transport (GO:1902803) | 2.58038969 |
| 38 | response to redox state (GO:0051775) | 2.56979533 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 2.56877709 |
| 40 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.56159728 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 2.53924018 |
| 42 | regulation of neuron projection regeneration (GO:0070570) | 2.53072721 |
| 43 | regulation of axon regeneration (GO:0048679) | 2.53072721 |
| 44 | regulation of beta-amyloid formation (GO:1902003) | 2.51636259 |
| 45 | presynaptic membrane organization (GO:0097090) | 2.50498561 |
| 46 | regulation of collateral sprouting (GO:0048670) | 2.50449325 |
| 47 | phagosome maturation (GO:0090382) | 2.49407001 |
| 48 | glycosphingolipid catabolic process (GO:0046479) | 2.49183116 |
| 49 | granulocyte activation (GO:0036230) | 2.48813167 |
| 50 | presynaptic membrane assembly (GO:0097105) | 2.47507802 |
| 51 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.47303770 |
| 52 | glutamate secretion (GO:0014047) | 2.47102892 |
| 53 | cholesterol biosynthetic process (GO:0006695) | 2.45634199 |
| 54 | neutrophil activation (GO:0042119) | 2.44073321 |
| 55 | transmission of nerve impulse (GO:0019226) | 2.43099141 |
| 56 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.42520049 |
| 57 | adult walking behavior (GO:0007628) | 2.41709501 |
| 58 | eosinophil chemotaxis (GO:0048245) | 2.41615434 |
| 59 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.41595156 |
| 60 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.41595156 |
| 61 | barbed-end actin filament capping (GO:0051016) | 2.41591630 |
| 62 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.41276222 |
| 63 | magnesium ion transport (GO:0015693) | 2.41141406 |
| 64 | potassium ion import (GO:0010107) | 2.40752426 |
| 65 | neuron remodeling (GO:0016322) | 2.39181902 |
| 66 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.38868352 |
| 67 | transferrin transport (GO:0033572) | 2.36745553 |
| 68 | glycolipid catabolic process (GO:0019377) | 2.34973850 |
| 69 | signal peptide processing (GO:0006465) | 2.32607353 |
| 70 | creatine metabolic process (GO:0006600) | 2.31856458 |
| 71 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.31693197 |
| 72 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.31083969 |
| 73 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.30100588 |
| 74 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.29620285 |
| 75 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.29580688 |
| 76 | copper ion homeostasis (GO:0055070) | 2.29118532 |
| 77 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.27687567 |
| 78 | GPI anchor biosynthetic process (GO:0006506) | 2.27416847 |
| 79 | neurotransmitter uptake (GO:0001504) | 2.26752778 |
| 80 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.25974580 |
| 81 | protein localization to synapse (GO:0035418) | 2.25223268 |
| 82 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.24864208 |
| 83 | negative regulation of interleukin-17 production (GO:0032700) | 2.24254859 |
| 84 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.23706878 |
| 85 | bone resorption (GO:0045453) | 2.23359679 |
| 86 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.23323356 |
| 87 | mast cell activation (GO:0045576) | 2.23013789 |
| 88 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.22382219 |
| 89 | amino sugar catabolic process (GO:0046348) | 2.22316555 |
| 90 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.20855076 |
| 91 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.20191408 |
| 92 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.20191408 |
| 93 | vocalization behavior (GO:0071625) | 2.19692429 |
| 94 | sterol biosynthetic process (GO:0016126) | 2.19416612 |
| 95 | COPI coating of Golgi vesicle (GO:0048205) | 2.19148193 |
| 96 | Golgi transport vesicle coating (GO:0048200) | 2.19148193 |
| 97 | trivalent inorganic cation transport (GO:0072512) | 2.19024149 |
| 98 | ferric iron transport (GO:0015682) | 2.19024149 |
| 99 | macrophage activation involved in immune response (GO:0002281) | 2.18540843 |
| 100 | amyloid precursor protein catabolic process (GO:0042987) | 2.17794127 |
| 101 | positive regulation of leukocyte degranulation (GO:0043302) | 2.17139917 |
| 102 | locomotory exploration behavior (GO:0035641) | 2.16917721 |
| 103 | virion attachment to host cell (GO:0019062) | 2.16346310 |
| 104 | adhesion of symbiont to host cell (GO:0044650) | 2.16346310 |
| 105 | negative regulation of interleukin-12 production (GO:0032695) | 2.15603320 |
| 106 | eosinophil migration (GO:0072677) | 2.15453909 |
| 107 | regulation of autophagic vacuole assembly (GO:2000785) | 2.15428352 |
| 108 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.15209281 |
| 109 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.15118857 |
| 110 | chaperone-mediated protein transport (GO:0072321) | 2.14790745 |
| 111 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.14625184 |
| 112 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.13712367 |
| 113 | establishment of mitochondrion localization (GO:0051654) | 2.13599454 |
| 114 | glutamate receptor signaling pathway (GO:0007215) | 2.13445036 |
| 115 | regulation of defense response to virus by virus (GO:0050690) | 2.12827228 |
| 116 | regulated secretory pathway (GO:0045055) | 2.12240856 |
| 117 | long-term synaptic potentiation (GO:0060291) | 2.12092036 |
| 118 | potassium ion homeostasis (GO:0055075) | 2.11709913 |
| 119 | oligosaccharide catabolic process (GO:0009313) | 2.11239231 |
| 120 | response to peptidoglycan (GO:0032494) | 2.10910141 |
| 121 | axon development (GO:0061564) | 2.09852430 |
| 122 | acidic amino acid transport (GO:0015800) | 2.09710863 |
| 123 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.09463469 |
| 124 | negative regulation of axonogenesis (GO:0050771) | 2.09183003 |
| 125 | L-glutamate transport (GO:0015813) | 2.08878382 |
| 126 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.08542964 |
| 127 | peptide catabolic process (GO:0043171) | 2.08363751 |
| 128 | adenosine receptor signaling pathway (GO:0001973) | 2.08229912 |
| 129 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.07467195 |
| 130 | protein palmitoylation (GO:0018345) | 2.07120907 |
| 131 | response to epinephrine (GO:0071871) | 2.07005193 |
| 132 | GPI anchor metabolic process (GO:0006505) | 2.06460700 |
| 133 | eye photoreceptor cell differentiation (GO:0001754) | 2.06023816 |
| 134 | photoreceptor cell differentiation (GO:0046530) | 2.06023816 |
| 135 | detection of other organism (GO:0098543) | 2.05854904 |
| 136 | negative regulation of lipid storage (GO:0010888) | 2.05844070 |
| 137 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.05740080 |
| 138 | positive regulation of type 2 immune response (GO:0002830) | 2.05677120 |
| 139 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.05593877 |
| 140 | import into cell (GO:0098657) | 2.05317178 |
| 141 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.04497402 |
| 142 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.02799125 |
| 143 | ceramide catabolic process (GO:0046514) | 2.02097669 |
| 144 | positive regulation of mast cell activation (GO:0033005) | 2.00340813 |
| 145 | sphingosine metabolic process (GO:0006670) | 2.00032064 |
| 146 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 1.98232634 |
| 147 | fibril organization (GO:0097435) | 1.98009672 |
| 148 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 1.97718100 |
| 149 | serine transport (GO:0032329) | 1.97156354 |
| 150 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 1.96557008 |
| 151 | regulation of type 2 immune response (GO:0002828) | 1.96542970 |
| 152 | regulation of mononuclear cell migration (GO:0071675) | 1.95541902 |
| 153 | positive regulation of gamma-delta T cell activation (GO:0046645) | 1.94263364 |
| 154 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 1.92873509 |
| 155 | positive regulation of macrophage differentiation (GO:0045651) | 1.91984359 |
| 156 | cellular response to arsenic-containing substance (GO:0071243) | 1.91844002 |
| 157 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 1.91439089 |
| 158 | regulation of regulatory T cell differentiation (GO:0045589) | 1.90948450 |
| 159 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 1.90256641 |
| 160 | regulation of T cell tolerance induction (GO:0002664) | 1.89701525 |
| 161 | detection of bacterium (GO:0016045) | 1.89087405 |
| 162 | regulation of fever generation (GO:0031620) | 1.88990634 |
| 163 | alpha-linolenic acid metabolic process (GO:0036109) | 1.88782737 |
| 164 | N-acetylneuraminate metabolic process (GO:0006054) | 1.88520150 |
| 165 | type I interferon signaling pathway (GO:0060337) | 1.88510202 |
| 166 | cellular response to type I interferon (GO:0071357) | 1.88510202 |
| 167 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 1.88482643 |
| 168 | regulation of metalloenzyme activity (GO:0048552) | 1.88179271 |
| 169 | L-serine transport (GO:0015825) | 1.87688327 |
| 170 | macrophage activation (GO:0042116) | 1.87610274 |
| 171 | regulation of interleukin-17 production (GO:0032660) | 1.87566481 |
| 172 | macroautophagy (GO:0016236) | 1.86982871 |
| 173 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 1.86775178 |
| 174 | protein localization to endosome (GO:0036010) | 1.86262821 |
| 175 | iron ion transport (GO:0006826) | 1.86171462 |
| 176 | diol metabolic process (GO:0034311) | 1.85729837 |
| 177 | T-helper 1 type immune response (GO:0042088) | 1.85391669 |
| 178 | lymphocyte chemotaxis (GO:0048247) | 1.84686844 |
| 179 | positive regulation of cholesterol transport (GO:0032376) | 1.84056398 |
| 180 | positive regulation of sterol transport (GO:0032373) | 1.84056398 |
| 181 | membrane lipid catabolic process (GO:0046466) | 1.83999358 |
| 182 | angiotensin maturation (GO:0002003) | 1.83977692 |
| 183 | regulation of monocyte chemotaxis (GO:0090025) | 1.83240720 |
| 184 | response to thyroid hormone (GO:0097066) | 1.83212438 |
| 185 | regulation of receptor recycling (GO:0001919) | 1.83163311 |
| 186 | regulation of mast cell degranulation (GO:0043304) | 1.82938200 |
| 187 | positive regulation of interleukin-1 secretion (GO:0050716) | 1.82876049 |
| 188 | response to type I interferon (GO:0034340) | 1.82359528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.69935515 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.64421937 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.58397895 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.53280489 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.44850314 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.44019295 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27793714 |
| 8 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.21288526 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.20551343 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.20303099 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.19481028 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.11927728 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.10134757 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.93537630 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.93537630 |
| 16 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.91287239 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.90638703 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89389610 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88393014 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.86578430 |
| 21 | * TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86284770 |
| 22 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.86186005 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84760060 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.81232045 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.79791866 |
| 26 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.77872373 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.75956654 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75722566 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74917496 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.73975934 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73177563 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67242006 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.63266909 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.62265487 |
| 35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.60872856 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56823636 |
| 37 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.56583815 |
| 38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.54033080 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51356799 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.50250445 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.46156591 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43929766 |
| 43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42533393 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.42310515 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41462439 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41450865 |
| 47 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.41070077 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38138328 |
| 49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34454273 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33340547 |
| 51 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.31028528 |
| 52 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.29723131 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29363481 |
| 54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21397148 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21115303 |
| 56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21097381 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21097381 |
| 58 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.21035743 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20972652 |
| 60 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19803070 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19279562 |
| 62 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14027854 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.13015855 |
| 64 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.12442745 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11769566 |
| 66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09670083 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09641556 |
| 68 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09342898 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09329768 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09176352 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08945044 |
| 72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.07798604 |
| 73 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07345483 |
| 74 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07321803 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07039689 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06308047 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05995626 |
| 78 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03610947 |
| 79 | * MYB_26560356_Chip-Seq_TH2_Human | 1.02897330 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02643510 |
| 81 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02404011 |
| 82 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02056902 |
| 83 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01318407 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00294794 |
| 85 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99407720 |
| 86 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.99197630 |
| 87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.99196078 |
| 88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98352372 |
| 89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.97495399 |
| 90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95903551 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95617660 |
| 92 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.94375111 |
| 93 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93710050 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93707433 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93500458 |
| 96 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93470589 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92268755 |
| 98 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.91744692 |
| 99 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.91315221 |
| 100 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91108365 |
| 101 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90197798 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89587169 |
| 103 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89556810 |
| 104 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89299142 |
| 105 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89000204 |
| 106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88968791 |
| 107 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88748738 |
| 108 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87804073 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86850562 |
| 110 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86502346 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86493615 |
| 112 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.86015940 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85986644 |
| 114 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85867255 |
| 115 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85686662 |
| 116 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85683119 |
| 117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85683119 |
| 118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85444204 |
| 119 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85316033 |
| 120 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85086544 |
| 121 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85052237 |
| 122 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84380388 |
| 123 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84234833 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83948139 |
| 125 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.83771151 |
| 126 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.83771151 |
| 127 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83503896 |
| 128 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83385460 |
| 129 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.83259887 |
| 130 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82553630 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82424700 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82292958 |
| 133 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.82250964 |
| 134 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.82130531 |
| 135 | GATA3_26560356_Chip-Seq_TH2_Human | 0.81970327 |
| 136 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.81420890 |
| 137 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.81397992 |
| 138 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.80945492 |
| 139 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.80594576 |
| 140 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80452809 |
| 141 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.79444508 |
| 142 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.78998258 |
| 143 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.78839560 |
| 144 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.78679003 |
| 145 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.78350163 |
| 146 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77627651 |
| 147 | JUN_21703547_ChIP-Seq_K562_Human | 0.77593142 |
| 148 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.77482856 |
| 149 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.77331443 |
| 150 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.77138356 |
| 151 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77060572 |
| 152 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.77024965 |
| 153 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.76787223 |
| 154 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76376799 |
| 155 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.75414869 |
| 156 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75305115 |
| 157 | KDM2B_26808549_Chip-Seq_REH_Human | 0.75069918 |
| 158 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.75020783 |
| 159 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.74846588 |
| 160 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.74649845 |
| 161 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74554453 |
| 162 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.74465241 |
| 163 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.74157167 |
| 164 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.73812460 |
| 165 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.73288824 |
| 166 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.73155833 |
| 167 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.71377643 |
| 168 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.71185771 |
| 169 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70850155 |
| 170 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.70631136 |
| 171 | GATA1_22025678_ChIP-Seq_K562_Human | 0.69958658 |
| 172 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67533880 |
| 173 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.67352004 |
| 174 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67197761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.84440579 |
| 2 | MP0000920_abnormal_myelination | 3.63127285 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.56587217 |
| 4 | MP0003329_amyloid_beta_deposits | 3.24095751 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.10433387 |
| 6 | MP0004270_analgesia | 2.77163995 |
| 7 | MP0003690_abnormal_glial_cell | 2.51582975 |
| 8 | MP0002064_seizures | 2.50348495 |
| 9 | MP0003635_abnormal_synaptic_transmissio | 2.47263006 |
| 10 | MP0003436_decreased_susceptibility_to | 2.41051325 |
| 11 | MP0002272_abnormal_nervous_system | 2.32348635 |
| 12 | MP0003303_peritoneal_inflammation | 2.25105122 |
| 13 | MP0009745_abnormal_behavioral_response | 2.21771090 |
| 14 | MP0001529_abnormal_vocalization | 2.19105188 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.16262521 |
| 16 | MP0000604_amyloidosis | 2.14816645 |
| 17 | MP0001905_abnormal_dopamine_level | 2.14448859 |
| 18 | MP0009046_muscle_twitch | 2.07290002 |
| 19 | MP0001486_abnormal_startle_reflex | 2.04465744 |
| 20 | MP0000343_altered_response_to | 2.02221738 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 2.02158494 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.95119236 |
| 23 | MP0002063_abnormal_learning/memory/cond | 1.94980171 |
| 24 | MP0001968_abnormal_touch/_nociception | 1.91816609 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 1.91654124 |
| 26 | MP0005171_absent_coat_pigmentation | 1.87840512 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.85185179 |
| 28 | MP0004510_myositis | 1.81941514 |
| 29 | MP0002735_abnormal_chemical_nociception | 1.80193928 |
| 30 | MP0002736_abnormal_nociception_after | 1.79851898 |
| 31 | MP0004142_abnormal_muscle_tone | 1.76653955 |
| 32 | MP0002572_abnormal_emotion/affect_behav | 1.72394934 |
| 33 | MP0003634_abnormal_glial_cell | 1.71335990 |
| 34 | MP0001970_abnormal_pain_threshold | 1.69331132 |
| 35 | MP0002822_catalepsy | 1.67383923 |
| 36 | MP0004742_abnormal_vestibular_system | 1.64761797 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.64531808 |
| 38 | MP0006082_CNS_inflammation | 1.61026059 |
| 39 | MP0009764_decreased_sensitivity_to | 1.60850891 |
| 40 | MP0001440_abnormal_grooming_behavior | 1.59006478 |
| 41 | MP0000685_abnormal_immune_system | 1.57092778 |
| 42 | MP0003633_abnormal_nervous_system | 1.56221600 |
| 43 | MP0008569_lethality_at_weaning | 1.55718849 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.55691908 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.54784028 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.54559542 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.51667857 |
| 48 | MP0003075_altered_response_to | 1.49765422 |
| 49 | MP0004885_abnormal_endolymph | 1.48318616 |
| 50 | MP0004858_abnormal_nervous_system | 1.45050850 |
| 51 | MP0002067_abnormal_sensory_capabilities | 1.44738866 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.43264604 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.41092150 |
| 54 | MP0002229_neurodegeneration | 1.40673794 |
| 55 | MP0000372_irregular_coat_pigmentation | 1.39598214 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.38227105 |
| 57 | MP0003631_nervous_system_phenotype | 1.38098012 |
| 58 | MP0004043_abnormal_pH_regulation | 1.36478128 |
| 59 | MP0001800_abnormal_humoral_immune | 1.35806528 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.34729862 |
| 61 | MP0003724_increased_susceptibility_to | 1.34656232 |
| 62 | MP0001542_abnormal_bone_strength | 1.33878642 |
| 63 | MP0005671_abnormal_response_to | 1.33177126 |
| 64 | MP0004147_increased_porphyrin_level | 1.32382224 |
| 65 | MP0004947_skin_inflammation | 1.32284212 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.32229550 |
| 67 | MP0005423_abnormal_somatic_nervous | 1.30762383 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.24651696 |
| 69 | MP0003632_abnormal_nervous_system | 1.22980561 |
| 70 | MP0005386_behavior/neurological_phenoty | 1.22584026 |
| 71 | MP0004924_abnormal_behavior | 1.22584026 |
| 72 | MP0009785_altered_susceptibility_to | 1.20616580 |
| 73 | MP0008469_abnormal_protein_level | 1.20296418 |
| 74 | MP0002405_respiratory_system_inflammati | 1.18841229 |
| 75 | MP0003448_altered_tumor_morphology | 1.17819975 |
| 76 | MP0005000_abnormal_immune_tolerance | 1.17476056 |
| 77 | MP0003866_abnormal_defecation | 1.16701759 |
| 78 | MP0003172_abnormal_lysosome_physiology | 1.15380638 |
| 79 | MP0001958_emphysema | 1.15165421 |
| 80 | MP0001485_abnormal_pinna_reflex | 1.15112270 |
| 81 | MP0001984_abnormal_olfaction | 1.14331969 |
| 82 | MP0002419_abnormal_innate_immunity | 1.11068000 |
| 83 | MP0005365_abnormal_bile_salt | 1.09102017 |
| 84 | MP0008260_abnormal_autophagy | 1.09050268 |
| 85 | MP0002066_abnormal_motor_capabilities/c | 1.08279356 |
| 86 | MP0001853_heart_inflammation | 1.08007922 |
| 87 | MP0005310_abnormal_salivary_gland | 1.07022432 |
| 88 | MP0005410_abnormal_fertilization | 1.05698885 |
| 89 | MP0002332_abnormal_exercise_endurance | 1.05232643 |
| 90 | MP0004883_abnormal_blood_vessel | 1.04953514 |
| 91 | MP0001502_abnormal_circadian_rhythm | 1.04896969 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 1.04419797 |
| 93 | MP0000778_abnormal_nervous_system | 1.03870195 |
| 94 | MP0003828_pulmonary_edema | 1.03851750 |
| 95 | MP0001835_abnormal_antigen_presentation | 1.03434677 |
| 96 | MP0006054_spinal_hemorrhage | 1.02327415 |
| 97 | MP0005164_abnormal_response_to | 1.01373723 |
| 98 | MP0002090_abnormal_vision | 1.00754771 |
| 99 | MP0003950_abnormal_plasma_membrane | 1.00702342 |
| 100 | MP0005646_abnormal_pituitary_gland | 1.00466657 |
| 101 | MP0010234_abnormal_vibrissa_follicle | 0.99194817 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 0.97557014 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 0.96844139 |
| 104 | MP0000015_abnormal_ear_pigmentation | 0.96804165 |
| 105 | MP0000955_abnormal_spinal_cord | 0.96233365 |
| 106 | MP0005551_abnormal_eye_electrophysiolog | 0.96208593 |
| 107 | MP0002882_abnormal_neuron_morphology | 0.95526076 |
| 108 | MP0009763_increased_sensitivity_to | 0.92619232 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.92178061 |
| 110 | MP0006276_abnormal_autonomic_nervous | 0.90838469 |
| 111 | MP0005025_abnormal_response_to | 0.90317211 |
| 112 | MP0002557_abnormal_social/conspecific_i | 0.89006810 |
| 113 | MP0003763_abnormal_thymus_physiology | 0.88751317 |
| 114 | MP0000858_altered_metastatic_potential | 0.87994149 |
| 115 | MP0003279_aneurysm | 0.87539464 |
| 116 | MP0004484_altered_response_of | 0.87025109 |
| 117 | MP0000716_abnormal_immune_system | 0.86817244 |
| 118 | MP0001177_atelectasis | 0.86252383 |
| 119 | MP0003186_abnormal_redox_activity | 0.85770299 |
| 120 | MP0002877_abnormal_melanocyte_morpholog | 0.85173582 |
| 121 | MP0000249_abnormal_blood_vessel | 0.84757727 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83452928 |
| 123 | MP0002295_abnormal_pulmonary_circulatio | 0.83082342 |
| 124 | MP0005535_abnormal_body_temperature | 0.82736562 |
| 125 | MP0008874_decreased_physiological_sensi | 0.82607185 |
| 126 | MP0008004_abnormal_stomach_pH | 0.82552952 |
| 127 | MP0001963_abnormal_hearing_physiology | 0.81540022 |
| 128 | MP0003879_abnormal_hair_cell | 0.81396222 |
| 129 | MP0001756_abnormal_urination | 0.81077803 |
| 130 | MP0001790_abnormal_immune_system | 0.80808993 |
| 131 | MP0005387_immune_system_phenotype | 0.80808993 |
| 132 | MP0001986_abnormal_taste_sensitivity | 0.80120274 |
| 133 | MP0002909_abnormal_adrenal_gland | 0.79619635 |
| 134 | MP0003091_abnormal_cell_migration | 0.79024475 |
| 135 | MP0001533_abnormal_skeleton_physiology | 0.78803757 |
| 136 | MP0002723_abnormal_immune_serum | 0.77990574 |
| 137 | MP0001851_eye_inflammation | 0.76889264 |
| 138 | MP0000013_abnormal_adipose_tissue | 0.76681188 |
| 139 | MP0004811_abnormal_neuron_physiology | 0.75688638 |
| 140 | MP0003795_abnormal_bone_structure | 0.75529197 |
| 141 | MP0005165_increased_susceptibility_to | 0.74368522 |
| 142 | MP0001664_abnormal_digestion | 0.73435355 |
| 143 | MP0001765_abnormal_ion_homeostasis | 0.73304132 |
| 144 | MP0005166_decreased_susceptibility_to | 0.72933711 |
| 145 | MP0002184_abnormal_innervation | 0.72305814 |
| 146 | MP0009840_abnormal_foam_cell | 0.72004579 |
| 147 | MP0005167_abnormal_blood-brain_barrier | 0.71887231 |
| 148 | MP0002420_abnormal_adaptive_immunity | 0.71852767 |
| 149 | MP0001819_abnormal_immune_cell | 0.70133933 |
| 150 | MP0005595_abnormal_vascular_smooth | 0.68198606 |
| 151 | MP0005390_skeleton_phenotype | 0.67518595 |
| 152 | MP0003453_abnormal_keratinocyte_physiol | 0.64359112 |
| 153 | MP0002118_abnormal_lipid_homeostasis | 0.63500032 |
| 154 | MP0009643_abnormal_urine_homeostasis | 0.62258343 |
| 155 | MP0005636_abnormal_mineral_homeostasis | 0.62099881 |
| 156 | MP0003045_fibrosis | 0.61736442 |
| 157 | MP0005085_abnormal_gallbladder_physiolo | 0.61307095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 5.35879798 |
| 2 | Supranuclear gaze palsy (HP:0000605) | 4.01690558 |
| 3 | Focal motor seizures (HP:0011153) | 3.93202049 |
| 4 | Cerebral inclusion bodies (HP:0100314) | 3.84982980 |
| 5 | Myokymia (HP:0002411) | 3.57994550 |
| 6 | Parakeratosis (HP:0001036) | 3.42276722 |
| 7 | Eczematoid dermatitis (HP:0000976) | 3.25998879 |
| 8 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.18672419 |
| 9 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.18672419 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 3.15831083 |
| 11 | Retinal dysplasia (HP:0007973) | 3.12400920 |
| 12 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.10038513 |
| 13 | Petechiae (HP:0000967) | 2.94248859 |
| 14 | Ankle clonus (HP:0011448) | 2.92059100 |
| 15 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.91350521 |
| 16 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.91350521 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.91350521 |
| 18 | Pheochromocytoma (HP:0002666) | 2.84917842 |
| 19 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.81834135 |
| 20 | Mucopolysacchariduria (HP:0008155) | 2.81834135 |
| 21 | Epileptic encephalopathy (HP:0200134) | 2.75394663 |
| 22 | Neuroendocrine neoplasm (HP:0100634) | 2.75285612 |
| 23 | Peripheral hypomyelination (HP:0007182) | 2.73984552 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 2.71065325 |
| 25 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.71065325 |
| 26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.71065325 |
| 27 | Purpura (HP:0000979) | 2.68444185 |
| 28 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.68375178 |
| 29 | Increased circulating renin level (HP:0000848) | 2.66176254 |
| 30 | Abnormality of macrophages (HP:0004311) | 2.64754245 |
| 31 | Hypokalemic alkalosis (HP:0001949) | 2.63542811 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 2.62568045 |
| 33 | Intention tremor (HP:0002080) | 2.59116004 |
| 34 | Acute necrotizing encephalopathy (HP:0006965) | 2.58232823 |
| 35 | Dysmetria (HP:0001310) | 2.57806361 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.57754815 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.52977420 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.52475882 |
| 39 | Myositis (HP:0100614) | 2.52165158 |
| 40 | Atonic seizures (HP:0010819) | 2.49479480 |
| 41 | Cerebral hemorrhage (HP:0001342) | 2.46513076 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.43661386 |
| 43 | Orchitis (HP:0100796) | 2.42570302 |
| 44 | Mitochondrial inheritance (HP:0001427) | 2.41369431 |
| 45 | Metabolic alkalosis (HP:0200114) | 2.40282914 |
| 46 | Focal seizures (HP:0007359) | 2.38008911 |
| 47 | Progressive neurologic deterioration (HP:0002344) | 2.37283624 |
| 48 | Visual hallucinations (HP:0002367) | 2.36603917 |
| 49 | Progressive inability to walk (HP:0002505) | 2.35194817 |
| 50 | Renal Fanconi syndrome (HP:0001994) | 2.35183325 |
| 51 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.33120714 |
| 52 | Slow saccadic eye movements (HP:0000514) | 2.32685779 |
| 53 | Abnormality of the corticospinal tract (HP:0002492) | 2.32332406 |
| 54 | Action tremor (HP:0002345) | 2.32187887 |
| 55 | Anxiety (HP:0000739) | 2.30524616 |
| 56 | Clumsiness (HP:0002312) | 2.29789007 |
| 57 | Absence seizures (HP:0002121) | 2.29118288 |
| 58 | Optic neuritis (HP:0100653) | 2.26017602 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.26017602 |
| 60 | Loss of speech (HP:0002371) | 2.25528949 |
| 61 | Abnormality of magnesium homeostasis (HP:0004921) | 2.24031545 |
| 62 | Spastic gait (HP:0002064) | 2.23993637 |
| 63 | Leukodystrophy (HP:0002415) | 2.23470281 |
| 64 | Megalencephaly (HP:0001355) | 2.21592679 |
| 65 | Split foot (HP:0001839) | 2.19193603 |
| 66 | Dialeptic seizures (HP:0011146) | 2.19056847 |
| 67 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.18461822 |
| 68 | Abnormality of binocular vision (HP:0011514) | 2.18110744 |
| 69 | Diplopia (HP:0000651) | 2.18110744 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.16984272 |
| 71 | Hepatocellular necrosis (HP:0001404) | 2.15417539 |
| 72 | Amyloidosis (HP:0011034) | 2.13136685 |
| 73 | Progressive macrocephaly (HP:0004481) | 2.12737841 |
| 74 | Chronic diarrhea (HP:0002028) | 2.11766415 |
| 75 | Hypomagnesemia (HP:0002917) | 2.11547355 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.10561764 |
| 77 | Cerebral hypomyelination (HP:0006808) | 2.09624119 |
| 78 | Hepatosplenomegaly (HP:0001433) | 2.08353612 |
| 79 | Generalized tonic-clonic seizures (HP:0002069) | 2.08120251 |
| 80 | Akinesia (HP:0002304) | 2.07028614 |
| 81 | Stomatitis (HP:0010280) | 2.06665170 |
| 82 | Mutism (HP:0002300) | 2.05987387 |
| 83 | Scanning speech (HP:0002168) | 2.05958866 |
| 84 | Recurrent abscess formation (HP:0002722) | 2.05446291 |
| 85 | Onion bulb formation (HP:0003383) | 2.05430974 |
| 86 | Asymmetric septal hypertrophy (HP:0001670) | 2.04699201 |
| 87 | Acute encephalopathy (HP:0006846) | 2.03792779 |
| 88 | Increased CSF protein (HP:0002922) | 2.01991918 |
| 89 | Gingival bleeding (HP:0000225) | 2.01815132 |
| 90 | Hyperaldosteronism (HP:0000859) | 2.01680373 |
| 91 | Disinhibition (HP:0000734) | 2.01169837 |
| 92 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.00090634 |
| 93 | Metaphyseal dysplasia (HP:0100255) | 1.99493411 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 1.98958204 |
| 95 | Chronic otitis media (HP:0000389) | 1.98548356 |
| 96 | Delusions (HP:0000746) | 1.97310823 |
| 97 | Increased hepatocellular lipid droplets (HP:0006565) | 1.96552560 |
| 98 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.94459520 |
| 99 | Type II lissencephaly (HP:0007260) | 1.94044524 |
| 100 | Mitral stenosis (HP:0001718) | 1.93032443 |
| 101 | Psychosis (HP:0000709) | 1.92161307 |
| 102 | Generalized myoclonic seizures (HP:0002123) | 1.91234628 |
| 103 | Hypothermia (HP:0002045) | 1.91140453 |
| 104 | Axonal loss (HP:0003447) | 1.90430771 |
| 105 | Recurrent skin infections (HP:0001581) | 1.89477965 |
| 106 | Increased serum pyruvate (HP:0003542) | 1.89174162 |
| 107 | Abnormality of glycolysis (HP:0004366) | 1.89174162 |
| 108 | Abnormal eating behavior (HP:0100738) | 1.88713854 |
| 109 | Premature loss of primary teeth (HP:0006323) | 1.88501610 |
| 110 | Neuronal loss in central nervous system (HP:0002529) | 1.86690465 |
| 111 | T lymphocytopenia (HP:0005403) | 1.86334664 |
| 112 | Hyperactive renin-angiotensin system (HP:0000841) | 1.85632438 |
| 113 | Progressive cerebellar ataxia (HP:0002073) | 1.85364146 |
| 114 | Pulmonary infiltrates (HP:0002113) | 1.84567721 |
| 115 | Arterial tortuosity (HP:0005116) | 1.84175830 |
| 116 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.84147479 |
| 117 | Abnormality of renal resorption (HP:0011038) | 1.83135849 |
| 118 | Sensory axonal neuropathy (HP:0003390) | 1.82748241 |
| 119 | Recurrent bacterial skin infections (HP:0005406) | 1.82654380 |
| 120 | Epistaxis (HP:0000421) | 1.81990606 |
| 121 | Spastic paraparesis (HP:0002313) | 1.80244509 |
| 122 | Increased CSF lactate (HP:0002490) | 1.79179764 |
| 123 | Nuclear cataract (HP:0100018) | 1.78777412 |
| 124 | Rigidity (HP:0002063) | 1.77821956 |
| 125 | Prolonged neonatal jaundice (HP:0006579) | 1.77402683 |
| 126 | Basal ganglia calcification (HP:0002135) | 1.77084914 |
| 127 | Prolonged bleeding time (HP:0003010) | 1.77027311 |
| 128 | Urticaria (HP:0001025) | 1.76926588 |
| 129 | Insidious onset (HP:0003587) | 1.76460047 |
| 130 | Termporal pattern (HP:0011008) | 1.76460047 |
| 131 | Growth hormone excess (HP:0000845) | 1.76289175 |
| 132 | Polyneuropathy (HP:0001271) | 1.76220108 |
| 133 | Polyphagia (HP:0002591) | 1.75076082 |
| 134 | Poor speech (HP:0002465) | 1.74857226 |
| 135 | Tetraparesis (HP:0002273) | 1.74491486 |
| 136 | Abnormality of renin-angiotensin system (HP:0000847) | 1.74378039 |
| 137 | Depression (HP:0000716) | 1.73715583 |
| 138 | Hematochezia (HP:0002573) | 1.73502067 |
| 139 | Vertebral compression fractures (HP:0002953) | 1.71712257 |
| 140 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.71305956 |
| 141 | Diminished motivation (HP:0000745) | 1.70973144 |
| 142 | Episodic fever (HP:0001954) | 1.70173807 |
| 143 | Glomerulonephritis (HP:0000099) | 1.69651810 |
| 144 | Amyotrophic lateral sclerosis (HP:0007354) | 1.67559846 |
| 145 | Apathy (HP:0000741) | 1.67559320 |
| 146 | Hyperlipoproteinemia (HP:0010980) | 1.66076070 |
| 147 | Conjunctival telangiectasia (HP:0000524) | 1.65953408 |
| 148 | Joint swelling (HP:0001386) | 1.65406303 |
| 149 | Hypergammaglobulinemia (HP:0010702) | 1.63561804 |
| 150 | Malnutrition (HP:0004395) | 1.62963119 |
| 151 | Abnormality of T cell number (HP:0011839) | 1.62658663 |
| 152 | Bone cyst (HP:0012062) | 1.62294958 |
| 153 | Steatorrhea (HP:0002570) | 1.61810078 |
| 154 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.61404866 |
| 155 | Dementia (HP:0000726) | 1.58786224 |
| 156 | Global brain atrophy (HP:0002283) | 1.57652644 |
| 157 | Mediastinal lymphadenopathy (HP:0100721) | 1.56276652 |
| 158 | Abnormality of the costochondral junction (HP:0000919) | 1.55957125 |
| 159 | Encephalitis (HP:0002383) | 1.55229455 |
| 160 | Abnormality of the motor neurons (HP:0002450) | 1.54570712 |
| 161 | Abnormal neuron morphology (HP:0012757) | 1.54570712 |
| 162 | Facial diplegia (HP:0001349) | 1.52696571 |
| 163 | Fat malabsorption (HP:0002630) | 1.51557606 |
| 164 | Abnormality of the periventricular white matter (HP:0002518) | 1.51407063 |
| 165 | Chronic obstructive pulmonary disease (HP:0006510) | 1.51037417 |
| 166 | Obstructive lung disease (HP:0006536) | 1.51037417 |
| 167 | Keratoconjunctivitis sicca (HP:0001097) | 1.50956133 |
| 168 | Pulmonary embolism (HP:0002204) | 1.49241680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 3.67470331 |
| 2 | TESK1 | 3.38467767 |
| 3 | OXSR1 | 2.96085638 |
| 4 | EPHA4 | 2.46084599 |
| 5 | RIPK4 | 2.36188624 |
| 6 | ARAF | 2.35968169 |
| 7 | PRPF4B | 2.23227241 |
| 8 | TNIK | 2.17608780 |
| 9 | CDK19 | 2.17079822 |
| 10 | MAP3K12 | 2.15770398 |
| 11 | EPHB1 | 1.98546642 |
| 12 | NTRK3 | 1.86955429 |
| 13 | MAP3K13 | 1.83336987 |
| 14 | NTRK1 | 1.80656065 |
| 15 | TYK2 | 1.76736082 |
| 16 | MST4 | 1.73441319 |
| 17 | TAOK3 | 1.73408868 |
| 18 | MAPKAPK5 | 1.72069308 |
| 19 | CSK | 1.64145743 |
| 20 | MAP3K3 | 1.64120165 |
| 21 | WNK4 | 1.63833552 |
| 22 | BCR | 1.61797574 |
| 23 | ERBB3 | 1.59615822 |
| 24 | TESK2 | 1.57056233 |
| 25 | FES | 1.55022723 |
| 26 | PIM2 | 1.50796910 |
| 27 | MAP3K9 | 1.47577086 |
| 28 | LMTK2 | 1.45944375 |
| 29 | PBK | 1.44890883 |
| 30 | MAPKAPK3 | 1.43581018 |
| 31 | PKN1 | 1.42898028 |
| 32 | LIMK1 | 1.40208151 |
| 33 | BLK | 1.39686463 |
| 34 | JAK1 | 1.39521791 |
| 35 | MYLK | 1.38105575 |
| 36 | MAP3K11 | 1.32342532 |
| 37 | TAOK1 | 1.29319435 |
| 38 | TGFBR2 | 1.28757132 |
| 39 | EPHA3 | 1.25330238 |
| 40 | TXK | 1.25248755 |
| 41 | ERN1 | 1.24639468 |
| 42 | MAP2K7 | 1.22303896 |
| 43 | CSF1R | 1.21852464 |
| 44 | CAMK2B | 1.21755566 |
| 45 | GRK6 | 1.20821585 |
| 46 | MINK1 | 1.19980893 |
| 47 | CASK | 1.19743295 |
| 48 | GRK7 | 1.19363932 |
| 49 | KSR2 | 1.19226067 |
| 50 | BMPR2 | 1.17548880 |
| 51 | SIK3 | 1.15835305 |
| 52 | MUSK | 1.15699807 |
| 53 | MAP3K5 | 1.08255008 |
| 54 | CAMKK2 | 1.07050975 |
| 55 | CDK5 | 1.05339882 |
| 56 | TIE1 | 1.03633987 |
| 57 | MAP3K2 | 1.01957749 |
| 58 | SGK223 | 1.01376326 |
| 59 | SGK494 | 1.01376326 |
| 60 | CAMK2D | 1.00741346 |
| 61 | FGR | 0.99611327 |
| 62 | TAOK2 | 0.97641886 |
| 63 | GRK5 | 0.97094851 |
| 64 | ROCK2 | 0.93465945 |
| 65 | IRAK3 | 0.92724556 |
| 66 | FER | 0.92513601 |
| 67 | ABL2 | 0.92211948 |
| 68 | NEK6 | 0.91731883 |
| 69 | MAP3K6 | 0.89892830 |
| 70 | CAMK2G | 0.89183158 |
| 71 | TRPM7 | 0.89145101 |
| 72 | PINK1 | 0.87899477 |
| 73 | MARK1 | 0.87244933 |
| 74 | CAMK2A | 0.87032356 |
| 75 | IKBKB | 0.85788041 |
| 76 | TBK1 | 0.85287234 |
| 77 | NME1 | 0.83148211 |
| 78 | PAK6 | 0.82531910 |
| 79 | NEK9 | 0.81800264 |
| 80 | IRAK4 | 0.81200718 |
| 81 | MAPK12 | 0.80858196 |
| 82 | UHMK1 | 0.79900663 |
| 83 | MAPK7 | 0.79558868 |
| 84 | PRKCQ | 0.79190885 |
| 85 | MAP3K1 | 0.78393312 |
| 86 | IKBKE | 0.78207643 |
| 87 | LYN | 0.78123777 |
| 88 | HCK | 0.77739656 |
| 89 | MAP4K1 | 0.76343512 |
| 90 | WNK1 | 0.76107787 |
| 91 | PDK2 | 0.76045102 |
| 92 | CDK14 | 0.76023927 |
| 93 | PHKG2 | 0.74699043 |
| 94 | PHKG1 | 0.74699043 |
| 95 | MOS | 0.74474448 |
| 96 | ADRBK2 | 0.74469401 |
| 97 | MAP3K14 | 0.74376769 |
| 98 | STK16 | 0.74291828 |
| 99 | MAPK13 | 0.73934609 |
| 100 | CSNK1G2 | 0.73648413 |
| 101 | PRKCE | 0.72820284 |
| 102 | CSNK1G3 | 0.71748547 |
| 103 | PDPK1 | 0.71262601 |
| 104 | NTRK2 | 0.69871173 |
| 105 | DAPK2 | 0.69835851 |
| 106 | JAK2 | 0.68347561 |
| 107 | BMPR1B | 0.67912680 |
| 108 | ACVR1B | 0.66140753 |
| 109 | BTK | 0.65362283 |
| 110 | KIT | 0.64232443 |
| 111 | KDR | 0.63073050 |
| 112 | PDK1 | 0.61853427 |
| 113 | PTK2B | 0.61438121 |
| 114 | CDK18 | 0.61052753 |
| 115 | FYN | 0.60586996 |
| 116 | IRAK2 | 0.60424945 |
| 117 | ITK | 0.59700684 |
| 118 | STK24 | 0.59538721 |
| 119 | IRAK1 | 0.59383404 |
| 120 | CDK15 | 0.59361560 |
| 121 | SCYL2 | 0.58792427 |
| 122 | TEC | 0.57945435 |
| 123 | PRKG2 | 0.57907260 |
| 124 | SYK | 0.56394107 |
| 125 | RIPK1 | 0.55961571 |
| 126 | PAK3 | 0.55826981 |
| 127 | PLK2 | 0.55715688 |
| 128 | MAP2K3 | 0.55613033 |
| 129 | CLK1 | 0.54171358 |
| 130 | CAMKK1 | 0.52820652 |
| 131 | MARK2 | 0.52188145 |
| 132 | TYRO3 | 0.52187941 |
| 133 | CDK11A | 0.51868539 |
| 134 | PIK3CG | 0.50706467 |
| 135 | CAMK1 | 0.49056434 |
| 136 | CSNK1A1L | 0.48971425 |
| 137 | FGFR2 | 0.48329469 |
| 138 | PIK3CA | 0.47653517 |
| 139 | PRKCH | 0.47164615 |
| 140 | PRKD3 | 0.45989201 |
| 141 | LCK | 0.45804551 |
| 142 | ABL1 | 0.44950984 |
| 143 | MAP3K4 | 0.44215106 |
| 144 | ZAP70 | 0.43987164 |
| 145 | TNK2 | 0.43763829 |
| 146 | MATK | 0.43690315 |
| 147 | PRKD1 | 0.42800553 |
| 148 | MAP2K4 | 0.42714627 |
| 149 | JAK3 | 0.41327667 |
| 150 | TRIM28 | 0.39856565 |
| 151 | EIF2AK1 | 0.38961938 |
| 152 | IGF1R | 0.38586203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.83904428 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.37436854 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.26037776 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.25958030 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.23832982 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.15727589 |
| 7 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.98907252 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.96634066 |
| 9 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.96186563 |
| 10 | Protein export_Homo sapiens_hsa03060 | 1.81577738 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.73184506 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72736925 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.72615674 |
| 14 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.68781558 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.67775517 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.67567982 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.66257334 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.65975673 |
| 19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.65279075 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.62453506 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.60618173 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59544379 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.55854227 |
| 24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.55050165 |
| 25 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.54683592 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54506916 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42721982 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.42643501 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.41803953 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38707889 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.38278403 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35917416 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.35750255 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.34952365 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.32055297 |
| 36 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31422804 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.28306312 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.25293906 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.24198268 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20748950 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20536673 |
| 42 | Long-term potentiation_Homo sapiens_hsa04720 | 1.20105514 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.20045241 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.18671745 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.12831973 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10829585 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.10319090 |
| 48 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.09058294 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08366382 |
| 50 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.07457245 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07353971 |
| 52 | Mineral absorption_Homo sapiens_hsa04978 | 1.05775613 |
| 53 | Long-term depression_Homo sapiens_hsa04730 | 1.03182452 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95137801 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94730042 |
| 56 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94259898 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 0.93851363 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.93691322 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92804596 |
| 60 | Taste transduction_Homo sapiens_hsa04742 | 0.92349158 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92149944 |
| 62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91483002 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91316652 |
| 64 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.90432710 |
| 65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90358642 |
| 66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.89808171 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89682097 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.88047923 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87811216 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87063497 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.86969351 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.85988807 |
| 73 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84177123 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82315254 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.81230871 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80114741 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79174741 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.76086526 |
| 79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75530250 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75497530 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75193379 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74800336 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72954097 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72443083 |
| 85 | Axon guidance_Homo sapiens_hsa04360 | 0.72233493 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72084738 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71418255 |
| 88 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71410588 |
| 89 | Tuberculosis_Homo sapiens_hsa05152 | 0.69470804 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68702877 |
| 91 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67832363 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66295616 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65265087 |
| 94 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65115766 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64956702 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.64437701 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.64336869 |
| 98 | Allograft rejection_Homo sapiens_hsa05330 | 0.64222777 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63843555 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63577915 |
| 101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62497021 |
| 102 | Malaria_Homo sapiens_hsa05144 | 0.61977905 |
| 103 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60999082 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | 0.60885337 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.60307158 |
| 106 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60226490 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60134636 |
| 108 | Phototransduction_Homo sapiens_hsa04744 | 0.59430363 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56847594 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56707310 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.56508374 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56003500 |
| 113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55065186 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.54375451 |
| 115 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54359521 |
| 116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54153156 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53575528 |
| 118 | Influenza A_Homo sapiens_hsa05164 | 0.53291904 |
| 119 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52291856 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51987278 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50974999 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50017236 |
| 123 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48572541 |
| 124 | Leishmaniasis_Homo sapiens_hsa05140 | 0.47104831 |
| 125 | Measles_Homo sapiens_hsa05162 | 0.47030853 |
| 126 | Gap junction_Homo sapiens_hsa04540 | 0.46875023 |
| 127 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46408412 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45936465 |
| 129 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.45004028 |
| 130 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.44240588 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.44074317 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42369910 |
| 133 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.41910589 |
| 134 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40406971 |
| 135 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40251187 |
| 136 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.39781226 |
| 137 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39033349 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38240612 |
| 139 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.38238560 |
| 140 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37107404 |
| 141 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36288126 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33409313 |
| 143 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31729313 |
| 144 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30943661 |
| 145 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30539851 |
| 146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30519758 |
| 147 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.29569460 |

